Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Stem cell serum effectively treated hair loss caused by COVID-19.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

About 61% of women who had COVID-19 experienced hair loss afterward.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

SIM01 significantly reduced post-COVID symptoms and is safe.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.